SSD Pharmaceuticals Private Limited
About SSD Pharmaceuticals Private Limited
Data last updated:
SSD Pharmaceuticals Private Limited is a private limited company based in Rajahmundry, Andhra Pradesh, India. It operates in the dyes and pigments segment of the chemicals and materials sector. It was incorporated on 18 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24110AP2020PTC114207.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandrasekhar Bejjipuram and Pavan Krishna Akula.
Its last annual general meeting (AGM) was held on 17 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 36 – 6 – 10/1 Market Street Innespeta, Rajahmundry, Andhra Pradesh, India – 533101.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address36 – 6 – 10/1 Market Street Innespeta, Rajahmundry, Andhra Pradesh, India – 533101
- IndustryChemicals and Materials, Dyes & Pigments, Colorants
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of SSD Pharmaceuticals Private Limited FY 2025 filings available
Financial Statement Summary of SSD Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of SSD Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of SSD Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of SSD Pharmaceuticals Private Limited
SSD Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandrasekhar Bejjipuram Also directs: SSD Interior Projects Private Limited, SSD Energy Private Limited | Director | 31 Jul 2021 | 5 Years 2 Months | Current |
| Pavan Krishna Akula Also directs: SSD Interior Projects Private Limited, SSD Energy Private Limited | Director | 16 Jun 2025 | 1 Years 3 Months | Current |
Charges & Borrowings of SSD Pharmaceuticals Private Limited
SSD Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at SSD Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to SSD Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on SSD Pharmaceuticals Private Limited
SSD Pharmaceuticals Private Limited has 6 board changes on record since 2021: 3 appointments and 3 cessations. The latest: Pavan Krishna Akula was appointed as Director on 16 Jun 2025.
Credit Ratings, Litigation & Regulatory Alerts for SSD Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by SSD Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of SSD Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of SSD Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of SSD Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SSD Pharmaceuticals Private Limited
SSD Pharmaceuticals is an active private limited company based in Rajahmundry, Andhra Pradesh, India. The company works in dyes and pigments, within the chemicals and materials industry. It was incorporated on 18 February 2020 (6+ years old) and is registered under CIN U24110AP2020PTC114207.
SSD Pharmaceuticals has 2 current directors:
- Chandrasekhar Bejjipuram - Director
- Pavan Krishna Akula - Director
The CIN (Corporate Identification Number) of SSD Pharmaceuticals is U24110AP2020PTC114207. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SSD Pharmaceuticals was incorporated on 18 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Vijayawada.
Pavan Krishna Akula was appointed as Director on 16 Jun 2025. Siva Satyanarayana Rao Bairi ceased to be Director on 16 Jun 2025. Chandrasekhar Bejjipuram was appointed as Director on 31 Jul 2021. SSD Pharmaceuticals has 6 board changes on record in total.
The registered office of SSD Pharmaceuticals is at 36 – 6 – 101 Market Street Innespeta, Rajahmundry, Andhra Pradesh, India – 533101.
SSD Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
SSD Pharmaceuticals operates in the chemicals and materials industry, in the dyes and pigments segment.
No. SSD Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.
SSD Pharmaceuticals can be reached at its registered office: 36 – 6 – 101 Market Street Innespeta, Rajahmundry, Andhra Pradesh, India – 533101.